Your browser doesn't support javascript.
loading
Association of celiac disease with eosinophilic esophagitis: Nationwide register-based cohort study with sibling analyses.
Mitselou, Niki; Uchida, Amiko; Roelstraete, Bjorn; Melén, Erik; Garber, John J; Katzka, David; Lebwohl, Benjamin; Green, Peter H R; Ludvigsson, Jonas F.
Afiliación
  • Mitselou N; Department of Pediatrics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Uchida A; Division of Gastroenterology, Hepatology & Nutrition, University of Utah School of Medicine, Salt Lake City, Utah.
  • Roelstraete B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Melén E; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Garber JJ; Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Katzka D; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Lebwohl B; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Green PHR; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Ludvigsson JF; Department of Pediatrics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
J Allergy Clin Immunol Glob ; 3(3): 100254, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38784439
ABSTRACT

Background:

Celiac disease (CeD) is associated with several immune-mediated disorders, but it is unclear whether it is associated with eosinophilic esophagitis (EoE).

Objective:

We sought to examine the risk of EoE in patients with biopsy-verified CeD compared with matched controls and siblings.

Methods:

Using nationwide population-based histopathology data, we identified 27,338 patients with CeD diagnosed in the period 2002 to 2017 in Sweden. Patients with CeD were age- and sex-matched with up to 5 reference individuals (n = 134,987) from the general population. Cox Regression was used to estimate hazard ratios (HRs) for developing biopsy-verified EoE. In a secondary analysis, we used unaffected siblings of patients with CeD as comparators to adjust for intrafamilial confounding.

Results:

The median age at CeD diagnosis was 27 years, and 63.3% were female patients. During a median follow-up of 8.1 years, 17 patients with CeD and 13 matched reference individuals were diagnosed with EoE. This corresponded to incidence rates of 0.08 versus 0.01 per 1000 person-years, respectively, and an adjusted HR for EoE of 6.65 (95% CI, 3.26-13.81). Compared with their siblings without CeD, patients with CeD were however at a no increased risk of EoE (HR, 1.39; 95% CI, 0.55-3.51).

Conclusions:

In this study, individuals with CeD were at a 6.6-fold increased risk of later EoE compared with the general population. This association might be explained by an altered health-seeking behavior or through shared genetic or early environmental factors because the excess risk disappeared in sibling analyses.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Año: 2024 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Año: 2024 Tipo del documento: Article País de afiliación: Suecia